$1.10
Today
as of Oct 2, 16:48 ET
Last 30 days
Recent Press Releases & News
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
DRMA earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.1% on average; after the most recent report on May 13, 2026 it moved -4.0%. The share price of $1.10 sits near its 52-week low.
Overview
52-week range
$0.95
$5.87
3% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-2.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.74 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.48 | — | — | -6.7% | -4.0% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-1.65 | — | — | — | — | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-1.66 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.45 | — | — | — | -0.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-20.41 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-41.82 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-7.06 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-2M | — | $-2M | $-2M | $-2M | — | $-3M |
| Net income | $-3M | $-2M | — | $-2M | $-2M | $-2M | — | $-3M |
| EPS (diluted) | $-0.74 | $-0.48 | — | $-1.65 | $-1.66 | $-4.47 | — | $-20.41 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $7M | $8M | $5M | $6M | $10M | $3M | — |
| Inventory | $149,734 | $93,091 | — | — | — | — | — | — |
| Total current assets | $5M | — | $8M | — | — | — | — | — |
| Total assets | $5M | $7M | $8M | $5M | $7M | $10M | $4M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $1M | $2M | $1M | $1M | $3M | $2M | $2M |
| Total equity | $3M | $6M | $6M | $4M | $6M | $7M | $2M | $5M |
Implied volatility — last 90 days
No IV snapshots yet for DRMA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
DRMA earnings FAQ
How does DRMA stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.1%, up 0 times and down 2 times.